Global Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15537652 | Publishing Date : 09-Apr-2020 | No. of pages : 99
Detailed TOC of Global Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Avacopan
1.4.3 Immune Globulin
1.4.4 Rituximab Biosimilar
1.4.5 Others
1.5 Market by Application
1.5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Microscopic Polyangiitis (MPA) Treatment Market Perspective (2015-2026)
2.2 Microscopic Polyangiitis (MPA) Treatment Growth Trends by Regions
2.2.1 Microscopic Polyangiitis (MPA) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Microscopic Polyangiitis (MPA) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Microscopic Polyangiitis (MPA) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Microscopic Polyangiitis (MPA) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Market Size
3.1.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Revenue (2015-2020)
3.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio
3.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019
3.3 Microscopic Polyangiitis (MPA) Treatment Key Players Head office and Area Served
3.4 Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service
3.5 Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Type (2021-2026)
5 Microscopic Polyangiitis (MPA) Treatment Breakdown Data by Application (2015-2026)
5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
5.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
6.2 Microscopic Polyangiitis (MPA) Treatment Key Players in North America (2019-2020)
6.3 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
6.4 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
7.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Europe (2019-2020)
7.3 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
7.4 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
8.2 Microscopic Polyangiitis (MPA) Treatment Key Players in China (2019-2020)
8.3 China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
8.4 China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
9.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Japan (2019-2020)
9.3 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
9.4 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
10.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
11.2 Microscopic Polyangiitis (MPA) Treatment Key Players in India (2019-2020)
11.3 India Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
11.4 India Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
12.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Celltrion Inc
13.1.1 Celltrion Inc Company Details
13.1.2 Celltrion Inc Business Overview and Its Total Revenue
13.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Introduction
13.1.4 Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020))
13.1.5 Celltrion Inc Recent Development
13.2 ChemoCentryx Inc
13.2.1 ChemoCentryx Inc Company Details
13.2.2 ChemoCentryx Inc Business Overview and Its Total Revenue
13.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Introduction
13.2.4 ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
13.2.5 ChemoCentryx Inc Recent Development
13.3 Sandoz International GmbH
13.3.1 Sandoz International GmbH Company Details
13.3.2 Sandoz International GmbH Business Overview and Its Total Revenue
13.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Introduction
13.3.4 Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
13.3.5 Sandoz International GmbH Recent Development
13.4 Teijin Pharma Ltd
13.4.1 Teijin Pharma Ltd Company Details
13.4.2 Teijin Pharma Ltd Business Overview and Its Total Revenue
13.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
13.4.4 Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
13.4.5 Teijin Pharma Ltd Recent Development
13.5 TTY Biopharm Company Ltd
13.5.1 TTY Biopharm Company Ltd Company Details
13.5.2 TTY Biopharm Company Ltd Business Overview and Its Total Revenue
13.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
13.5.4 TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
13.5.5 TTY Biopharm Company Ltd Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Microscopic Polyangiitis (MPA) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue
Table 3. Ranking of Global Top Microscopic Polyangiitis (MPA) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Avacopan
Table 6. Key Players of Immune Globulin
Table 7. Key Players of Rituximab Biosimilar
Table 8. Key Players of Others
Table 9. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2015-2020)
Table 13. Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Microscopic Polyangiitis (MPA) Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Microscopic Polyangiitis (MPA) Treatment Players
Table 20. Global Microscopic Polyangiitis (MPA) Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players (2015-2020)
Table 22. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019)
Table 23. Global Microscopic Polyangiitis (MPA) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service
Table 26. Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Type (2015-2020)
Table 30. Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2015-2020)
Table 32. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 36. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 38. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 42. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 44. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 48. China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 50. China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 54. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 56. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 60. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 66. India Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 68. India Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 72. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 76. Celltrion Inc Company Details
Table 77. Celltrion Inc Business Overview
Table 78. Celltrion Inc Product
Table 79. Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 80. Celltrion Inc Recent Development
Table 81. ChemoCentryx Inc Company Details
Table 82. ChemoCentryx Inc Business Overview
Table 83. ChemoCentryx Inc Product
Table 84. ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 85. ChemoCentryx Inc Recent Development
Table 86. Sandoz International GmbH Company Details
Table 87. Sandoz International GmbH Business Overview
Table 88. Sandoz International GmbH Product
Table 89. Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 90. Sandoz International GmbH Recent Development
Table 91. Teijin Pharma Ltd Company Details
Table 92. Teijin Pharma Ltd Business Overview
Table 93. Teijin Pharma Ltd Product
Table 94. Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 95. Teijin Pharma Ltd Recent Development
Table 96. TTY Biopharm Company Ltd Company Details
Table 97. TTY Biopharm Company Ltd Business Overview
Table 98. TTY Biopharm Company Ltd Product
Table 99. TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 100. TTY Biopharm Company Ltd Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Avacopan Features
Figure 3. Immune Globulin Features
Figure 4. Rituximab Biosimilar Features
Figure 5. Others Features
Figure 6. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Microscopic Polyangiitis (MPA) Treatment Report Years Considered
Figure 11. Global Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players in 2019
Figure 16. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019
Figure 18. North America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Celltrion Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Celltrion Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 27. ChemoCentryx Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. ChemoCentryx Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 29. Sandoz International GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sandoz International GmbH Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 31. Teijin Pharma Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teijin Pharma Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 33. TTY Biopharm Company Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. TTY Biopharm Company Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed
Keyplayers in Global Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2020-2026
Celltrion IncChemoCentryx Inc
Sandoz International GmbH
Teijin Pharma Ltd
TTY Biopharm Company Ltd